Cargando…

Engineered exosomes from different sources for cancer-targeted therapy

Exosome is a subgroup of extracellular vesicles, which has been serving as an efficient therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes modified with surface decoration and internal therapeutic molecules. After appropriate modification, engineered exosomes are abl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Menghui, Hu, Shengyun, Liu, Lin, Dang, Pengyuan, Liu, Yang, Sun, Zhenqiang, Qiao, Bingbing, Wang, Chengzeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017761/
https://www.ncbi.nlm.nih.gov/pubmed/36922504
http://dx.doi.org/10.1038/s41392-023-01382-y
_version_ 1784907661845725184
author Zhang, Menghui
Hu, Shengyun
Liu, Lin
Dang, Pengyuan
Liu, Yang
Sun, Zhenqiang
Qiao, Bingbing
Wang, Chengzeng
author_facet Zhang, Menghui
Hu, Shengyun
Liu, Lin
Dang, Pengyuan
Liu, Yang
Sun, Zhenqiang
Qiao, Bingbing
Wang, Chengzeng
author_sort Zhang, Menghui
collection PubMed
description Exosome is a subgroup of extracellular vesicles, which has been serving as an efficient therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes modified with surface decoration and internal therapeutic molecules. After appropriate modification, engineered exosomes are able to deliver antitumor drugs to tumor sites efficiently and precisely with fewer treatment-related adverse effects. However, there still exist many challenges for the clinical translation of engineered exosomes. For instance, what sources and modification strategies could endow exosomes with the most efficient antitumor activity is still poorly understood. Additionally, how to choose appropriately engineered exosomes in different antitumor therapies is another unresolved problem. In this review, we summarized the characteristics of engineered exosomes, especially the spatial and temporal properties. Additionally, we concluded the recent advances in engineered exosomes in the cancer fields, including the sources, isolation technologies, modification strategies, and labeling and imaging methods of engineered exosomes. Furthermore, the applications of engineered exosomes in different antitumor therapies were summarized, such as photodynamic therapy, gene therapy, and immunotherapy. Consequently, the above provides the cancer researchers in this community with the latest ideas on engineered exosome modification and new direction of new drug development, which is prospective to accelerate the clinical translation of engineered exosomes for cancer-targeted therapy.
format Online
Article
Text
id pubmed-10017761
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100177612023-03-17 Engineered exosomes from different sources for cancer-targeted therapy Zhang, Menghui Hu, Shengyun Liu, Lin Dang, Pengyuan Liu, Yang Sun, Zhenqiang Qiao, Bingbing Wang, Chengzeng Signal Transduct Target Ther Review Article Exosome is a subgroup of extracellular vesicles, which has been serving as an efficient therapeutic tool for various diseases. Engineered exosomes are the sort of exosomes modified with surface decoration and internal therapeutic molecules. After appropriate modification, engineered exosomes are able to deliver antitumor drugs to tumor sites efficiently and precisely with fewer treatment-related adverse effects. However, there still exist many challenges for the clinical translation of engineered exosomes. For instance, what sources and modification strategies could endow exosomes with the most efficient antitumor activity is still poorly understood. Additionally, how to choose appropriately engineered exosomes in different antitumor therapies is another unresolved problem. In this review, we summarized the characteristics of engineered exosomes, especially the spatial and temporal properties. Additionally, we concluded the recent advances in engineered exosomes in the cancer fields, including the sources, isolation technologies, modification strategies, and labeling and imaging methods of engineered exosomes. Furthermore, the applications of engineered exosomes in different antitumor therapies were summarized, such as photodynamic therapy, gene therapy, and immunotherapy. Consequently, the above provides the cancer researchers in this community with the latest ideas on engineered exosome modification and new direction of new drug development, which is prospective to accelerate the clinical translation of engineered exosomes for cancer-targeted therapy. Nature Publishing Group UK 2023-03-15 /pmc/articles/PMC10017761/ /pubmed/36922504 http://dx.doi.org/10.1038/s41392-023-01382-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review Article
Zhang, Menghui
Hu, Shengyun
Liu, Lin
Dang, Pengyuan
Liu, Yang
Sun, Zhenqiang
Qiao, Bingbing
Wang, Chengzeng
Engineered exosomes from different sources for cancer-targeted therapy
title Engineered exosomes from different sources for cancer-targeted therapy
title_full Engineered exosomes from different sources for cancer-targeted therapy
title_fullStr Engineered exosomes from different sources for cancer-targeted therapy
title_full_unstemmed Engineered exosomes from different sources for cancer-targeted therapy
title_short Engineered exosomes from different sources for cancer-targeted therapy
title_sort engineered exosomes from different sources for cancer-targeted therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017761/
https://www.ncbi.nlm.nih.gov/pubmed/36922504
http://dx.doi.org/10.1038/s41392-023-01382-y
work_keys_str_mv AT zhangmenghui engineeredexosomesfromdifferentsourcesforcancertargetedtherapy
AT hushengyun engineeredexosomesfromdifferentsourcesforcancertargetedtherapy
AT liulin engineeredexosomesfromdifferentsourcesforcancertargetedtherapy
AT dangpengyuan engineeredexosomesfromdifferentsourcesforcancertargetedtherapy
AT liuyang engineeredexosomesfromdifferentsourcesforcancertargetedtherapy
AT sunzhenqiang engineeredexosomesfromdifferentsourcesforcancertargetedtherapy
AT qiaobingbing engineeredexosomesfromdifferentsourcesforcancertargetedtherapy
AT wangchengzeng engineeredexosomesfromdifferentsourcesforcancertargetedtherapy